Table 2.

Previous published clinical studies using DCE-MRI to assess response to anti-angiogenic therapy in renal cancer.

Authors [Reference]	Year	Number of Patients Included in Analysis	Anti-Angiogenic Therapy
Flaherty et al. [17]	2008	15	Sorafenib
Hahn et al. [24]	2008	44	Sorafenib
Sweis et al. [25]	2017	17	Pazopanib
Hudson et al. [26]	2018	34	Sunitinib
Desar et al. [27]	2011	10	Sunitinib